» Articles » PMID: 27687734

Sonoreperfusion Therapy Kinetics in Whole Blood Using Ultrasound, Microbubbles and Tissue Plasminogen Activator

Overview
Specialty Radiology
Date 2016 Oct 1
PMID 27687734
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Coronary intervention for myocardial infarction often results in microvascular embolization of thrombus. Sonoreperfusion therapy (SRP) using ultrasound and microbubbles restored perfusion in our in vitro flow model of microvascular obstruction. In this study, we assessed SRP efficacy using whole blood as the perfusate with and without tissue plasminogen activator (tPA). In a phantom vessel bearing a 40-μm-pore mesh to simulate the microvasculature, microthrombi were injected to cause microvascular obstruction and were treated using SRP. Without tPA, the lytic rate increased from 2.6 ± 1.5 mmHg/min with 1000-cycle pulses to 7.3 ± 3.2 mmHg/min with 5000-cycle ultrasound pulses (p < 0.01). The lytic index was similar for tPA-only ([2.0 ± 0.5] × 10 mmHg min) and 5000 cycles without tPA ([2.3 ± 0.5] × 10 mmHg min) (p = 0.5) but increased ([3.6 ± 0.8] × 10 mmHg min) with tPA in conjunction with 5000-cycles ultrasound (p < 0.01). In conclusion, SRP restored microvascular perfusion in whole blood, SRP lytic rate in experiments without tPA increased with ultrasound pulse length and efficacy increased with the addition of tPA.

Citing Articles

Focused Ultrasound: Noninvasive Image-Guided Therapy.

Moonen C, Kilroy J, Klibanov A Invest Radiol. 2024; 60(3):205-219.

PMID: 39163359 PMC: 11801465. DOI: 10.1097/RLI.0000000000001116.


Effect of Ultrasound Pulse Length on Sonoreperfusion Therapy.

Yu F, Amjad M, Mohammed S, Yu G, Chen X, Pacella J Ultrasound Med Biol. 2022; 49(1):152-164.

PMID: 36253230 PMC: 9712163. DOI: 10.1016/j.ultrasmedbio.2022.08.009.


Sonoreperfusion therapy for microvascular obstruction: A step toward clinical translation.

Istvanic F, Yu G, Yu F, Powers J, Chen X, Pacella J Ultrasound Med Biol. 2020; 46(3):712-720.

PMID: 31924423 PMC: 7010545. DOI: 10.1016/j.ultrasmedbio.2019.11.011.


Drug-Loaded Microbubbles Combined with Ultrasound for Thrombolysis and Malignant Tumor Therapy.

Gong Q, Gao X, Liu W, Hong T, Chen C Biomed Res Int. 2019; 2019:6792465.

PMID: 31662987 PMC: 6791276. DOI: 10.1155/2019/6792465.


In vitro characterization of sonothrombolysis and echocontrast agents to treat ischemic stroke.

Shekhar H, Kleven R, Peng T, Palaniappan A, Karani K, Huang S Sci Rep. 2019; 9(1):9902.

PMID: 31289285 PMC: 6616381. DOI: 10.1038/s41598-019-46112-z.


References
1.
Kloner R, GANOTE C, Jennings R . The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974; 54(6):1496-508. PMC: 301706. DOI: 10.1172/JCI107898. View

2.
Chen X, Wang J, Pacella J, Villanueva F . Dynamic Behavior of Microbubbles during Long Ultrasound Tone-Burst Excitation: Mechanistic Insights into Ultrasound-Microbubble Mediated Therapeutics Using High-Speed Imaging and Cavitation Detection. Ultrasound Med Biol. 2015; 42(2):528-538. PMC: 4698009. DOI: 10.1016/j.ultrasmedbio.2015.09.017. View

3.
Mehran R, Lansky A, Witzenbichler B, Guagliumi G, Peruga J, Brodie B . Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet. 2009; 374(9696):1149-59. DOI: 10.1016/S0140-6736(09)61484-7. View

4.
Tanswell P, Tebbe U, Neuhaus K, Wojcik J, Seifried E . Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. J Am Coll Cardiol. 1992; 19(5):1071-5. DOI: 10.1016/0735-1097(92)90297-z. View

5.
Leeman J, Kim J, Yu F, Chen X, Kim K, Wang J . Effect of acoustic conditions on microbubble-mediated microvascular sonothrombolysis. Ultrasound Med Biol. 2012; 38(9):1589-98. DOI: 10.1016/j.ultrasmedbio.2012.05.020. View